Cardiovascular Business

New national coalition pushes for wider cardiac PET adoption

The Cardiac PET Alliance includes a majority of cardiac PET providers in the United States and supports practices performing ...
Cardiovascular Business

American Society of Nuclear Cardiology updates cardiac stress testing guideline

The new ASNC document includes detailed SPECT- and PET-specific protocols, new patient preparation recommendations and a ...
Radiology Business

Physician groups launch national alliance to protect PET imaging access

The launch comes ahead of meetings with members of Congress this fall in Washington, D.C., where group leaders plan to ...

Cardiac PET Alliance Launches to Protect Patient Access to the Nation's Most Advanced Non-Invasive Cardiac Imaging Technology

The Cardiac PET Alliance today announced its formal launch as the nation's only physician-led organization dedicated exclusively to advancing cardiac positron emission tomography (PET) imaging, ...

ASNC Releases New Guideline for Stress Testing in SPECT and PET Myocardial Perfusion Imaging

Lane Duvall, MD, MASNC, chair and lead author of the guideline FAIRFAX, VA, UNITED STATES, September 8, 2026 /EINPresswire.com/ — The American Society of Nuclear Cardiology (ASNC) today announced ...

Catalyst MedTech Helps Imaging Providers See What’s Next in Nuclear Cardiology at ASNC 2026

Company to Showcase Expanded Digirad® Cardiac SPECT Portfolio, PET/CT Solutions, Windows 11 Modernization and Nationwide ...
Nasdaq

GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET Imaging

GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...
TCTMD

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

A new radioactive tracer for positron emission tomography (PET) myocardial perfusion imaging will soon be available in the United States, and it’s expected to facilitate substantial growth in such ...
Milwaukee Journal Sentinel

Cardiac PET with Myocardial Blood Flow Is Now the Preferred Test for Evaluating Coronary Artery Disease in All Patients

Based on the clinical and scientific evidence now available, there are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded.” — Timothy Bateman, ...
Medical Xpress

New PET imaging model for quantifying cardiac amyloidosis can enable more accurate diagnosis and monitoring

Researchers have identified the optimal tracer kinetic model to quantify 18 F-flutemetamol myocardial uptake in patients with transthyretin (ATTR) cardiac amyloidosis. Presented at the 2023 Society of ...
FT Markets

Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026

Bayer today announced the presentation of first detailed results from the Phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital, that evaluated the investigational ...

Bayer’s experimental PET tracer shows accuracy in Phase 3 cardiac amyloidosis

Bayer (BAYZF) said an experimental imaging agent accurately identified cardiac amyloidosis in a Phase 3 study, producing sensitivity of 94% and specificity of 86% based on agreement among independent ...